<?xml version="1.0" encoding="UTF-8"?>
<p>Immunotherapy is considered an effective method for the clinical treatment of infectious diseases. There are two main approaches in immunotherapy: passive immunization using antibodies isolated from the blood of the infected patients and the monoclonal antibodies (MAs) therapy and active immunization via vaccines [
 <xref rid="B146-jcm-09-02084" ref-type="bibr">146</xref>]. The passive immunization by early administration of convalescent plasma or hyper-immune immunoglobulin from patients that contains significant antibody titers might be efficient in reducing the viral load and disease mortality, but there are some factors that need to be elucidated before treatment initiation, such as the availability of sufficient donors, clinical condition, viral kinetics, and host interactions of SARS-CoV-2 [
 <xref rid="B12-jcm-09-02084" ref-type="bibr">12</xref>,
 <xref rid="B35-jcm-09-02084" ref-type="bibr">35</xref>].
</p>
